05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
On April 22, 2020, the Chamber of Deputies of the Czech Republic rejected changes suggested by the S...
Read More >
The DE OFCCP Week in Review (WIR) is a simple, fast and direct summary of relevant happenings in the...
Read More >
On this joint edition of Williams Mullen's Benefits Companion and GovCon Perspectives podcasts, Bryd...
Read More >
Just before the end of its session, the New York Legislature expanded protections against discrimina...
Read More >
Department of Treasury Issues Final FIRRMA Regulations - The U.S. Treasury Department has issued fi...
Read More >
Seyfarth Synopsis: Recently the U.S. House of Representatives passed a bill with bipartisan support ...
Read More >